tradingkey.logo
tradingkey.logo
Search

Adaptive Biotechnologies Corp

ADPT
Add to Watchlist
22.570USD
-1.610-6.66%
Close 07-31 16:00ETQuotes delayed by 15 min
3.59BMarket Cap
LossP/E TTM

ADPT Financials

See Adaptive Biotechnologies Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Adaptive Biotechnologies Corp Earnings Date

Latest Release
Jul 29, 2026
EPS / Forecast
-0.25/-0.13
Revenue / Forecast
71.55M/65.89M
Period
FY2025 Earnings
Revenue(YoY)
276.98M
54.77%
EPS(YoY)
-0.39
63.83%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-47.79%-0.25
35.62%-0.13
61.13%-0.09
128.80%0.06
46.29%-0.17
38.60%-0.20
52.39%-0.23
37.45%-0.22
5.30%-0.31
18.95%-0.33
-70.84%-0.48
---0.35
---0.33
---0.40
---0.28
---1.12
----
----
----
----
----
Revenue
21.53%71.55M
35.14%70.87M
51.04%71.68M
102.38%93.97M
36.33%58.88M
25.24%52.44M
3.66%47.46M
22.46%46.44M
-11.72%43.19M
11.23%41.87M
-17.05%45.78M
-20.72%37.92M
12.06%48.93M
-2.52%37.65M
45.53%55.20M
21.19%47.83M
13.39%43.66M
0.46%38.62M
25.66%37.93M
50.07%39.47M
----
Net Profit
-55.34%-39.79M
32.89%-20.03M
59.70%-13.58M
129.77%9.55M
44.58%-25.61M
37.16%-29.85M
51.48%-33.69M
36.24%-32.07M
3.32%-46.22M
17.66%-47.51M
-73.05%-69.44M
-11.08%-50.30M
8.14%-47.81M
8.03%-57.70M
34.68%-40.13M
19.00%-45.28M
-5.57%-52.05M
-54.36%-62.74M
-37.83%-61.43M
-52.25%-55.90M
----
Net Margin
-28.42%-55.82%
50.35%-28.24%
73.34%-18.94%
114.69%10.16%
59.41%-43.47%
49.89%-56.88%
53.18%-71.04%
47.92%-69.12%
-9.58%-107.08%
25.93%-113.52%
-108.50%-151.73%
---132.72%
---97.72%
---153.27%
---72.77%
---123.13%
----
----
----
----
----
Gross Margin
3.66%71.23%
9.26%73.01%
21.12%73.98%
26.97%80.22%
26.56%68.71%
19.58%66.82%
8.64%61.08%
32.04%63.19%
-13.17%54.29%
13.43%55.88%
-18.72%56.22%
--47.85%
--62.53%
--49.27%
--69.17%
--67.27%
----
----
----
----
----
Debt to assets ratio
94.35%52.27%
-1.30%25.80%
3.56%25.59%
13.10%26.87%
19.09%26.89%
23.29%26.14%
25.03%24.71%
31.25%23.76%
34.71%22.58%
32.15%21.21%
35.05%19.76%
--18.10%
--16.76%
--16.05%
--14.63%
--14.09%
----
----
----
----
----
Revenue
21.53%71.55M
35.14%70.87M
51.04%71.68M
102.38%93.97M
36.33%58.88M
25.24%52.44M
3.66%47.46M
22.46%46.44M
-11.72%43.19M
11.23%41.87M
-17.05%45.78M
-20.72%37.92M
12.06%48.93M
-2.52%37.65M
45.53%55.20M
21.19%47.83M
13.39%43.66M
0.46%38.62M
25.66%37.93M
50.07%39.47M
----
Operating profit
37.01%-15.77M
35.12%-19.21M
62.15%-12.77M
131.72%10.29M
36.51%-25.04M
37.96%-29.60M
26.05%-33.75M
36.34%-32.44M
17.54%-39.43M
16.57%-47.72M
-16.47%-45.64M
-12.16%-50.96M
8.92%-47.82M
6.95%-57.19M
36.38%-39.19M
19.34%-45.43M
-5.50%-52.50M
-48.90%-61.47M
-39.23%-61.60M
-52.03%-56.33M
----
Net Profit
-55.34%-39.79M
32.89%-20.03M
59.70%-13.58M
129.77%9.55M
44.58%-25.61M
37.16%-29.85M
51.48%-33.69M
36.24%-32.07M
3.32%-46.22M
17.66%-47.51M
-73.05%-69.44M
-11.08%-50.30M
8.14%-47.81M
8.03%-57.70M
34.68%-40.13M
19.00%-45.28M
-5.57%-52.05M
-54.36%-62.74M
-37.83%-61.43M
-52.25%-55.90M
----
Current assets
60.61%420.56M
13.77%291.81M
5.79%300.19M
-8.73%281.44M
-25.51%261.86M
-31.43%256.49M
-30.82%283.75M
-29.15%308.35M
-26.27%351.55M
-25.39%374.03M
-27.03%410.19M
-22.88%435.24M
8.72%476.81M
19.62%501.33M
39.58%562.15M
20.85%564.38M
-31.87%438.57M
-45.21%419.12M
-44.59%402.75M
-46.77%467.03M
----
Total current liabilities
-4.81%87.71M
-0.91%87.01M
-8.30%89.92M
-4.87%83.36M
4.56%92.14M
5.86%87.81M
11.40%98.05M
-6.08%87.63M
-7.56%88.13M
-7.93%82.95M
-19.83%88.02M
-10.31%93.30M
-14.47%95.33M
-21.70%90.10M
-3.53%109.79M
-15.01%104.02M
-4.44%111.47M
7.77%115.07M
8.18%113.81M
21.37%122.38M
----
Total assets
29.00%640.68M
-0.96%505.94M
-4.94%512.74M
-12.16%490.61M
-15.09%496.64M
-17.65%510.85M
-18.42%539.38M
-22.18%558.51M
-23.50%584.87M
-21.62%620.32M
-22.82%661.13M
-18.83%717.68M
-5.22%764.54M
-7.78%791.46M
-7.23%856.62M
-10.92%884.21M
-21.94%806.63M
-19.95%858.19M
-17.29%923.34M
-9.39%992.61M
----
Total liabilities
54.53%490.02M
-12.14%281.70M
-14.59%287.74M
-14.50%286.36M
-7.67%317.10M
-7.21%320.63M
-4.52%336.89M
-5.93%334.93M
-6.82%343.44M
-5.97%345.56M
-10.10%352.86M
-10.18%356.05M
27.84%368.57M
20.52%367.51M
22.95%392.52M
16.22%396.39M
-15.22%288.32M
-11.96%304.94M
-14.45%319.24M
6.44%341.06M
----
Total equity
-16.08%150.66M
17.88%224.24M
11.12%225.00M
-8.64%204.25M
-25.64%179.54M
-30.77%190.22M
-34.32%202.49M
-38.18%223.57M
-39.03%241.43M
-35.19%274.77M
-33.57%308.28M
-25.87%361.64M
-23.61%395.97M
-23.37%423.95M
-23.18%464.10M
-25.13%487.81M
-25.24%518.32M
-23.76%553.25M
-18.72%604.10M
-15.94%651.54M
----
Net operating income
----
66.52%-9.54M
116.45%2.06M
73.67%-7.13M
28.16%-12.43M
25.73%-28.48M
53.62%-12.49M
42.03%-27.07M
26.55%-17.30M
35.16%-38.35M
10.28%-26.93M
-10.08%-46.68M
49.95%-23.56M
8.22%-59.15M
44.23%-30.02M
2.38%-42.41M
-26.47%-47.06M
-10.66%-64.45M
-35.09%-53.83M
7.87%-43.44M
-19.74%-37.21M
Net investment
----
-64.25%9.14M
-137.31%-8.25M
226.90%17.28M
-43.07%3.35M
-42.54%25.57M
589.71%22.12M
-79.77%5.29M
-84.25%5.88M
-29.33%44.51M
103.29%3.21M
-54.95%26.14M
686.41%37.32M
67.11%62.98M
-245.13%-97.54M
372.78%58.02M
-88.55%4.75M
-59.83%37.69M
119.77%67.21M
78.13%-21.27M
-76.65%41.45M
Net financing
----
37.59%7.50M
16953.54%21.66M
4110.00%1.68M
5266.67%1.61M
12288.64%5.45M
45.98%127.00K
135.29%40.00K
-97.96%30.00K
-93.45%44.00K
1350.00%87.00K
-99.99%17.00K
-63.18%1.47M
-75.55%672.00K
-99.82%6.00K
4189.82%125.52M
-36.95%3.99M
-81.19%2.75M
-47.58%3.28M
-98.94%2.93M
-0.14%6.33M

FAQs

What is the total revenue of Adaptive Biotechnologies Corp?

According to Adaptive Biotechnologies Corp's FY2025 earnings report, its total revenue reached 276.98M, with a year-on-year change of 178.96M.

What are the current assets of Adaptive Biotechnologies Corp?

According to Adaptive Biotechnologies Corp's FY2025 earnings report, its current assets were 300.19M, with a year-on-year change of 5.79.

What are the total assets of Adaptive Biotechnologies Corp?

According to Adaptive Biotechnologies Corp's FY2025 earnings report, its total assets of Adaptive Biotechnologies Corp were 512.74M, with a year-on-year change of -4.94.

What are the total liabilities of Adaptive Biotechnologies Corp?

According to Adaptive Biotechnologies Corp's FY2025 earnings report, its total liabilities of Adaptive Biotechnologies Corp were 287.74M, with a year-on-year change of -14.59.

What is the total equity of Adaptive Biotechnologies Corp?

According to Adaptive Biotechnologies Corp's FY2025 earnings report, its total equity of Adaptive Biotechnologies Corp was 225.00M, with a year-on-year change of 11.12.

What is the net operating income of Adaptive Biotechnologies Corp?

According to Adaptive Biotechnologies Corp's FY2025 earnings report, its net operating income of Adaptive Biotechnologies Corp was -57.12M, with a year-on-year change of 62.75.

What is the net investment of Adaptive Biotechnologies Corp?

According to Adaptive Biotechnologies Corp's FY2025 earnings report, its net investment of Adaptive Biotechnologies Corp was 37.95M, with a year-on-year change of -51.22.

What is the net financing of Adaptive Biotechnologies Corp?

According to Adaptive Biotechnologies Corp's FY2025 earnings report, its net financing of Adaptive Biotechnologies Corp was 30.40M, with a year-on-year change of 12515.35.

What is the Earnings Per Share (EPS) of Adaptive Biotechnologies Corp?

According to Adaptive Biotechnologies Corp's FY2025 earnings report, its Earnings Per Share (EPS) was -0.39, with a year-on-year change of 63.83.

What is the net income of Adaptive Biotechnologies Corp?

According to Adaptive Biotechnologies Corp's FY2025 earnings report, its net income was -59.50M, with a year-on-year change of 62.69.

What is the net margin of Adaptive Biotechnologies Corp?

According to Adaptive Biotechnologies Corp's FY2025 earnings report, its net profit margin was -21.47, with a year-on-year change of 75.93.

What is the gross margin of Adaptive Biotechnologies Corp?

According to Adaptive Biotechnologies Corp's FY2025 earnings report, its gross margin was 73.62, with a year-on-year change of 25.27.

What is the debt-to-asset ratio of Adaptive Biotechnologies Corp?

According to Adaptive Biotechnologies Corp's FY2025 earnings report, its debt-to-asset ratio was 25.59, with a year-on-year change of 3.56.

What is the Return on Equity (ROE) of Adaptive Biotechnologies Corp?

According to Adaptive Biotechnologies Corp's FY2025 earnings report, its Return on Equity (ROE) was -28.23, with a year-on-year change of 54.76.

What is the Return on Assets (ROA) of Adaptive Biotechnologies Corp?

According to Adaptive Biotechnologies Corp's FY2025 earnings report, its Return on Assets (ROA) was -11.30, with a year-on-year change of 57.49.

What is the operating profit of Adaptive Biotechnologies Corp?

According to Adaptive Biotechnologies Corp's FY2025 earnings report, its operating profit was -57.12M, with a year-on-year change of 62.75.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.